Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT01919619Phase 2Completed
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies
B-Cell Non-Hodgkin LymphomaHematopoietic and Lymphoid Cell NeoplasmLeukemia+3 more
PrincipalinvestigatorStart date: 2013-11-04
NCT01664910Phase 1/2Completed
CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
Hematopoietic and Lymphoid Cell Neoplasm
PrincipalinvestigatorStart date: 2012-10-29
NCT00439556Phase 2Completed
Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
CD20 PositiveHematopoietic and Lymphoid Cell NeoplasmLymphocytic Neoplasm+1 more
PrincipalinvestigatorStart date: 2007-02-13

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score8%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

LymphomaMultiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score8%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

LeukemiaHematopoietic and Lymphoid Cell Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score8%

Anjali Advani, MD

The Cleveland Clinic

Related
7 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma
Similarity Score8%

Meir Wetzler, MD

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Farhad Ravandi, MD

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

LeukemiaLymphoma
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01919619Phase 2PrincipalInvestigator

Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies

B-Cell Non-Hodgkin LymphomaHematopoietic and Lymphoid Cell NeoplasmLeukemia+3 more
Completed
NCT01664910Phase 1/2PrincipalInvestigator

CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

Hematopoietic and Lymphoid Cell Neoplasm
Completed
NCT00439556Phase 2PrincipalInvestigator

Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant

CD20 PositiveHematopoietic and Lymphoid Cell NeoplasmLymphocytic Neoplasm+1 more
Completed

All 3 trials loaded